Oxford Pharmascience has 'exciting' potential as growth continues
У вашего броузера проблема в совместимости с HTML5
Nigel Theobald, CEO of Oxford Pharmascience (LON:OXP), tells Proactiveinvestors that the second half has started strongly. Having established the technology platforms Nigel says that the company is now focused on areas that have 'huge' potential.